New figures released this month by the Office for National Statistics (ONS) show a stark rise in liver cancer deaths, prompting Liver Cancer UK, part of the British Liver Trust, to call for urgent public health action.
The new data shows that deaths from liver cancer in England and Wales increased by 41% between 2013 and 2024 with the disease now accounting for a greater share of overall deaths than in previous years. The sharp increase highlights the critical need for better prevention efforts and earlier diagnosis.
Despite advances in treatment for many cancers, liver cancer remains one of the deadliest, with survival rates heavily dependent on early diagnosis and proactive monitoring of high-risk groups. Currently, only around 13% of people diagnosed with liver cancer will survive for five years or more and just 8% will survive for ten years.
Liver cancer is one of the fastest rising causes of cancer death in the UK, with approximately 6,000 deaths annually – equating to 17 deaths per day. It often presents with subtle symptoms, making early diagnosis challenging. Common signs include:
- Unexplained weight loss
- Jaundice (yellowing of the skin or eyes)
- Abdominal pain or swelling
- Loss of appetite
- Nausea or vomiting
- Fatigue
Detecting the disease at an early stage is crucial, as it greatly increases the chances of survival.
Pamela Healy OBE, Chief Executive at the British Liver Trust, said:
“This data paints a bleak picture for people diagnosed with liver cancer. If we’re going to change the narrative of rising mortality rates we urgently need a comprehensive public health strategy which includes expanding access to screening and early detection services, promoting lifestyle changes to reduce risk factors and increasing public awareness about liver cancer symptoms and prevention.”
Liver Cancer UK is urging the public to be aware of the risks and to seek medical advice if they believe they could be affected. They are also calling on the NHS to prioritise the identification and screening of individuals at high risk, including those with hepatitis, chronic liver disease, obesity, or a history of heavy alcohol use.
Campaign Collective is a campaign partner to the British Liver Trust.